K. Dobbin

P. Corso, K. Dobbin, A. Okwera, 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Use of Genomic Technologies to Identify Novel Genetic Abnormalities and Therapeutic Targets In Acute Lymphoblastic Leukemia.

J. Downing, M. Relling, D. Gerhard, 2008 .

Access and Utilization of Asthma Medications Among Patients Who Receive Care in Federally Qualified Health Centers

K. Dobbin, L. Guglani, Anne H. Gaglioti, 2022, Journal of primary care & community health.

Cost-Effectiveness Analysis of Community Active Case Finding and Household Contact Investigation for Tuberculosis Case Detection in Urban Africa

P. Corso, K. Dobbin, A. Okwera, 2015, PloS one.

Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia.

J. Downing, K. Dobbin, C. Mullighan, 2010, Blood.

Rearrangement of CRLF 2 is associated with mutation of JAK kinases , alteration of IKZF 1 , Hispanic / Latino ethnicity , and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia *

J. Downing, K. Dobbin, C. Mullighan, 2010 .

Evaluating biomarkers for treatment selection from reproducibility studies.

K. Dobbin, Xiao Song, 2020, Biostatistics.

Video directly observed therapy for supporting and monitoring adherence to tuberculosis treatment in Uganda: a pilot cohort study

R. Garfein, K. Dobbin, L. Atuyambe, 2020, ERJ Open Research.

Masitinib demonstrates anti-proliferative and pro-apoptotic activity in primary and metastatic feline injection-site sarcoma cells.

K. Dobbin, M. Vandenplas, D. Hurley, 2012, Veterinary and comparative oncology.

How Large a Training Set is Needed to Develop a Classifier for Microarray Data?

Yingdong Zhao, Richard M Simon, Kevin K Dobbin, 2008, Clinical Cancer Research.

Autotaxin exacerbates tumor progression by enhancing MEK1 and overriding the function of miR-489-3p.

G. Mills, K. Dobbin, Mandi M. Murph, 2018, Cancer letters.

SEG - A Software Program for Finding Somatic Copy Number Alterations in Whole Genome Sequencing Data of Cancer

Jie Tang, Deli Liu, Yuan Feng, 2018, Computational and structural biotechnology journal.

Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

Igor Jurisica, Kerby Shedden, Steven Eschrich, 2008, Nature Medicine.

Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation

K. Dobbin, L. Butterfield, S. Selvan, 2016, Journal of Immunotherapy for Cancer.

Optimally splitting cases for training and testing high dimensional classifiers

Kevin K Dobbin, Richard M Simon, R. Simon, 2011, BMC Medical Genomics.

Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays.

Kenneth H Buetow, James W Jacobson, Kevin K Dobbin, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

pediatric B-progenitor acute lymphoblastic leukemia , Hispanic / Latino ethnicity , and a poor outcome in IKZF 1 alteration of kinases , JAK is associated with mutation of CRLF 2 Rearrangement of

J. Downing, K. Dobbin, C. Mullighan, 2010 .

Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations

K. Dobbin, L. Butterfield, S. Selvan, 2016, Journal of Immunotherapy for Cancer.

Proliferative and Invasive Colorectal Tumors in Pet Dogs Provide Unique Insights into Human Colorectal Cancer

Shaying Zhao, K. Dobbin, Tianfang Wang, 2018, Cancers.

Canine tumor mutational burden is correlated with TP53 mutation across tumor types and breeds

Shaying Zhao, K. Dobbin, Tianfang Wang, 2021, Nature Communications.

Statistical Design of Reverse Dye Microarrays

Kevin Dobbin, Richard Simon, Joanna H. Shih, 2003, Bioinform..

Comparison of microarray designs for class comparison and class discovery

Kevin Dobbin, Richard Simon, R. Simon, 2002, Bioinform..

Questions and answers on design of dual-label microarrays for identifying differentially expressed genes.

Richard Simon, R. Simon, K. Dobbin, 2003, Journal of the National Cancer Institute.

Sample size determination for training cancer classifiers from microarray and RNA-seq data

Xiao Song, Sandra Safo, Kevin K. Dobbin, 2015, 1509.04897.

Sample size requirements for training high-dimensional risk predictors.

Xiao Song, Kevin K Dobbin, K. Dobbin, 2013, Biostatistics.

Lower confidence bounds for prediction accuracy in high dimensions via AROHIL Monte Carlo

Kevin K. Dobbin, Stephanie Cooke, K. Dobbin, 2011, Bioinform..

Accommodating stochastic departures from percentile invariance in causal models

T. Louis, K. Dobbin, 2003 .

Covariance adjustment for batch effect in gene expression data

Jeongyoun Ahn, Jung Ae Lee, Kevin K Dobbin, 2014, Statistics in medicine.

Health and personal resources in older patients with cancer undergoing chemotherapy.

K. Dobbin, P. Jacobsen, M. Extermann, 2013, Journal of geriatric oncology.

Effects of pooling mRNA in microarray class comparisons

Kevin Dobbin, Joanna H. Shih, Jeffrey E. Green, 2004, Bioinform..

Time to blood, respiratory and urine culture positivity in the intensive care unit: Implications for de-escalation

K. Dobbin, A. Newsome, C. Forehand, 2021, SAGE open medicine.

Impact of a Rapid Point of Care Test for Influenza on Guideline Consistent Care and Antibiotic Use

M. Ebell, K. Dobbin, A. Handel, 2019, The Journal of the American Board of Family Medicine.

Comparison of confidence interval methods for an intra-class correlation coefficient (ICC)

Kevin K Dobbin, Lisa M McShane, Alexei C Ionan, 2014, BMC Medical Research Methodology.

Characterizing dye bias in microarray experiments

K. K. Dobbin, Ernest S. Kawasaki, D. W. Petersen, 2005, Bioinform..

Human basal-like breast cancer is represented by one of the two mammary tumor subtypes in dogs

Shaying Zhao, K. Dobbin, Tianfang Wang, 2023, bioRxiv.

Defining adequate contact for transmission of Mycobacterium tuberculosis in an African urban environment

M. Ebell, M. Castellanos, K. Dobbin, 2020, BMC Public Health.

Should we expect all-cause mortality reductions in large screening studies?

M. Ebell, K. Dobbin, 2018, The British journal of general practice : the journal of the Royal College of General Practitioners.

Immune monitoring technology primer

K. Dobbin, 2015, Journal of Immunotherapy for Cancer.

Urban-Rural Disparities in Treatment Outcomes Among Recurrent TB Cases in Zambia

K. Dobbin, V. Marconi, S. Mutembo, 2019 .

The tissue microarray data exchange specification: implementation by the Cooperative Prostate Cancer Tissue Resource

Ashok Patel, Jules J. Berman, Michael J. Becich, 2004, BMC Bioinformatics.

Experimental design of DNA microarray experiments.

K. Dobbin, R. Simon, Richard M Simon, 2003, BioTechniques.

Statistical design and evaluation of biomarker studies.

K. Dobbin, 2014, Methods in molecular biology.

Using a Mobile Health Intervention (DOT Selfie) With Transfer of Social Bundle Incentives to Increase Treatment Adherence in Tuberculosis Patients in Uganda: Protocol for a Randomized Controlled Trial

K. Dobbin, L. Atuyambe, E. Buregyeya, 2020, JMIR research protocols.

Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents

M. Grever, S. Groshen, M. Ratain, 2010, Clinical Cancer Research.

Prostate cancer in patients with screening serum prostate specific antigen values less than 4.0 ng/dl: results from the cooperative prostate cancer tissue resource.

Ashokkumar A. Patel, M. Becich, R. Dhir, 2005, The Journal of urology.

Health and personal resources in older patients with cancer undergoing chemotherapy.

K. Dobbin, P. Jacobsen, M. Extermann, 2013, Journal of geriatric oncology.

In reply to 'Active case finding for tuberculosis: what is the most informative measure for policy makers?'.

P. Corso, K. Dobbin, A. Okwera, 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

dimensional DNA microarray data

Richard M. Simon, Kevin K. Dobbin, K. Dobbin, 2006 .

How Large a Training Set is Needed to Develop a Classifier for Microarray Data?

K. Dobbin, Yingdong Zhao, R. Simon, 2008, Clinical Cancer Research.

CHARACTERIZATION OF THE PROPORTION OF CLUSTERED TUBERCULOSIS CASES IN 1 GUATEMALA, CA: INSIGHTS FROM A MOLECULAR EPIDEMIOLOGY STUDY, 2010-2014. 2

M. Ebell, M. Castellanos, K. Dobbin, 2020 .

Sample size methods for constructing confidence intervals for the intra-class correlation coefficient

Kevin K. Dobbin, Alexei C. Ionan, K. Dobbin, 2015, Comput. Stat. Data Anal..

Masitinib demonstrates anti-proliferative and pro-apoptotic activity in primary and metastatic feline injection-site sarcoma cells.

K. Dobbin, R. Gogal, O. Lamberth, 2012, Veterinary and comparative oncology.